1. Home
  2. ADMA vs PAY Comparison

ADMA vs PAY Comparison

Compare ADMA & PAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • PAY
  • Stock Information
  • Founded
  • ADMA 2004
  • PAY 2004
  • Country
  • ADMA United States
  • PAY United States
  • Employees
  • ADMA N/A
  • PAY N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • PAY Computer Software: Prepackaged Software
  • Sector
  • ADMA Health Care
  • PAY Technology
  • Exchange
  • ADMA Nasdaq
  • PAY Nasdaq
  • Market Cap
  • ADMA 5.1B
  • PAY 4.4B
  • IPO Year
  • ADMA N/A
  • PAY 2021
  • Fundamental
  • Price
  • ADMA $16.21
  • PAY $32.91
  • Analyst Decision
  • ADMA Strong Buy
  • PAY Buy
  • Analyst Count
  • ADMA 3
  • PAY 7
  • Target Price
  • ADMA $27.67
  • PAY $36.50
  • AVG Volume (30 Days)
  • ADMA 2.9M
  • PAY 779.0K
  • Earning Date
  • ADMA 11-06-2025
  • PAY 11-11-2025
  • Dividend Yield
  • ADMA N/A
  • PAY N/A
  • EPS Growth
  • ADMA 469.09
  • PAY 69.57
  • EPS
  • ADMA 0.85
  • PAY 0.44
  • Revenue
  • ADMA $474,174,000.00
  • PAY $1,044,760,000.00
  • Revenue This Year
  • ADMA $21.08
  • PAY $31.46
  • Revenue Next Year
  • ADMA $25.98
  • PAY $20.33
  • P/E Ratio
  • ADMA $19.06
  • PAY $74.85
  • Revenue Growth
  • ADMA 43.58
  • PAY 49.35
  • 52 Week Low
  • ADMA $13.50
  • PAY $19.53
  • 52 Week High
  • ADMA $25.67
  • PAY $40.43
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 39.23
  • PAY 35.85
  • Support Level
  • ADMA $15.74
  • PAY $32.52
  • Resistance Level
  • ADMA $17.17
  • PAY $35.97
  • Average True Range (ATR)
  • ADMA 0.51
  • PAY 1.22
  • MACD
  • ADMA -0.08
  • PAY -0.79
  • Stochastic Oscillator
  • ADMA 23.51
  • PAY 7.43

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About PAY Paymentus Holdings Inc.

Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.

Share on Social Networks: